UK Vein Clinic Group Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—6

Registered number: 12651713

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Intangible Assets	4		51,513		-
Tangible Assets	5		154,312		154,728
Investments	6		29,857		29,857

			235,682		184,585
CURRENT ASSETS
Stocks	7	-		88,403
Debtors	8	1,131,326		3,314,039
Cash at bank and in hand		319,070		405,927

		1,450,396		3,808,369
Creditors: Amounts Falling Due Within One Year	9	(139,781 )		(62,950 )

NET CURRENT ASSETS (LIABILITIES)			1,310,615		3,745,419

TOTAL ASSETS LESS CURRENT LIABILITIES			1,546,297		3,930,004

Creditors: Amounts Falling Due After More Than One Year	10		(1,500,000 )		(3,781,717 )

PROVISIONS FOR LIABILITIES
Deferred Taxation			(26,848 )		(38,682 )

NET ASSETS			19,449		109,605

CAPITAL AND RESERVES
Called up share capital	11		1,990		1,990
Share premium account			303		303
Capital redemption reserve			(24,990 )		(24,990 )
Profit and Loss Account			42,146		132,302

SHAREHOLDERS' FUNDS			19,449		109,605

Page 1

Page 2

UK Vein Clinic Group Limited

Balance Sheet (continued)

As At 31 December 2025

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr J E Powell

Director

2 July 2026

The notes on pages 3 to 6 form part of these financial statements.

1. General Information

UK Vein Clinic Group Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12651713 . The registered office is Lower Ground Floor, 150 Harley Street, London, W1G 7LQ.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Intangible Fixed Assets and Amortisation - Other Intangible

Other intangible assets are start up cost. It is amortised to the profit and loss account over its estimated economic life of 30 years.

2.4. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery	20 % Straight Line
Fixtures & Fittings	20 % Straight Line
Computer Equipment	20 % Straight Line

2.5. Stocks and Work in Progress

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

2.6. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

...CONTINUED

Page 3

Page 4

UK Vein Clinic Group Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

2.6. Taxation - continued

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 43 (2024: 36)

4. Intangible Assets

	Other
	£
Cost
As at 1 January 2025	-
Additions	52,537

As at 31 December 2025	52,537

Amortisation
As at 1 January 2025	-
Provided during the period	1,024

As at 31 December 2025	1,024

Net Book Value
As at 31 December 2025	51,513

As at 1 January 2025	-

5. Tangible Assets

	Plant & Machinery	Fixtures & Fittings	Computer Equipment	Total
	£	£	£	£
Cost
As at 1 January 2025	1,157	9,472	315,013	325,642
Additions	37,387	-	51,305	88,692

As at 31 December 2025	38,544	9,472	366,318	414,334

Depreciation
As at 1 January 2025	280	996	169,638	170,914
Provided during the period	260	983	87,865	89,108

As at 31 December 2025	540	1,979	257,503	260,022

Net Book Value
As at 31 December 2025	38,004	7,493	108,815	154,312

As at 1 January 2025	877	8,476	145,375	154,728

Page 4

Page 5

UK Vein Clinic Group Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

6. Investments

	Other
	£
Cost
As at 1 January 2025	29,857

As at 31 December 2025	29,857

Provision
As at 1 January 2025	-

As at 31 December 2025	-

Net Book Value
As at 31 December 2025	29,857

As at 1 January 2025	29,857

7. Stocks

	2025	2024
	£	£
Stock	-	88,403

8. Debtors

	2025	2024
	£	£
Due within one year
Prepayments and accrued income	117,784	132,019
Other debtors	17,600	6,200
Directors' loan accounts	31,567	-

	166,951	138,219
Due after more than one year
Amounts owed by group undertakings	964,375	3,175,820

	1,131,326	3,314,039

9. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Trade creditors	150	(294 )
Corporation tax	10,654	-
Other taxes and social security	58,202	47,993
Other creditors	143	9,451
Accruals and deferred income	56,532	5,800
Directors' loan accounts	14,100	-

	139,781	62,950

Page 5

Page 6

UK Vein Clinic Group Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

10. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Bank loans	1,500,000	1,500,000
Amounts owed to group undertakings	-	2,281,717

	1,500,000	3,781,717

11. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	1,990	1,990

12. Directors Advances, Credits and Guarantees

Included within Debtors are the following loans to directors:£31,567.

The above loan is unsecured, interest free and repayable by 1st of October 2025.

13. Related Party Transactions

Dr Newmans Clinic Limited - Intercompany balance: Dr £523,509, (2024 Dr £2,566,158)

UK Vein Clinic Ltd - Intercompany balance: Dr £440,865, (2024 Cr £2,281,717)

Uk Vein Clinic (Thames Valley) Ltd - Intercompany balance: £Nil, (2024 Dr £424,578)

Uk Vein Clinic Cambridge Ltd - Intercompany balance: £Nil, (2024 Dr £96,935)

Uk Vein Clinic Surrey Ltd - Intercompany balance: £Nil (2024 Dr £88,149)

14. Ultimate Controlling Party

There is no company's controlling party, due to shareholders holding equal amount of shares.

Page 6